Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

SMS Pharmaceuticals Ltd

Pharmaceuticals & Biotechnology | Small Cap

SMS Pharmaceuticals Ltd Health Insights
Health Score : 5.94Health Score : 5.94

SMS Pharmaceuticals demonstrates a mixed financial profile. The company shows strong solvency and profitability, indicating a solid foundation and efficient management of resources. Revenue and asset growth are also robust, suggesting expansion and effective use of assets. However, the company faces challenges in efficiency, particularly in inventory and receivables management. Earnings per share and net income growth have been volatile, reflecting potential instability in earnings. Liquidity is adequate, but there is room to improve short-term financial obligations. Overall, SMS Pharmaceuticals exhibits financial strengths but needs to address certain operational inefficiencies and earnings inconsistencies to enhance its long-term financial health.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025-26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
SMS Pharmaceuticals Ltd Health Insights
Health Score : 5.94Health Score : 5.94

SMS Pharmaceuticals demonstrates a mixed financial profile. The company shows strong solvency and profitability, indicating a solid foundation and efficient management of resources. Revenue and asset growth are also robust, suggesting expansion and effective use of assets. However, the company faces challenges in efficiency, particularly in inventory and receivables management. Earnings per share and net income growth have been volatile, reflecting potential instability in earnings. Liquidity is adequate, but there is room to improve short-term financial obligations. Overall, SMS Pharmaceuticals exhibits financial strengths but needs to address certain operational inefficiencies and earnings inconsistencies to enhance its long-term financial health.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025-26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

40.02

Neutral

Industry Median

28.93

Neutral
Overvalued

Small Cap Median

26.92

Overvalued

P/E RATIO

34.36

P/B RATIO

4.46

Overvalued

Industry Median

3.18

Overvalued
Highly Overvalued

Small Cap Median

2.63

Highly Overvalued

P/S RATIO

3.90

Neutral

Industry Median

3.41

Neutral
Highly Overvalued

Small Cap Median

2.40

Highly Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

19.93

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹374.15 as on Jun 18, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report7th Feb 26

Quarterly Financial Results Q3 FY 2025-26

NEUTRAL SENTIMENT

Concall Report11th Nov 25

Q2 & H1 FY26 Earnings Conference Call

NEUTRAL SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 6.00

The growth ratios show positive trends in revenue and asset growth, but inconsistencies in earnings per share and net income growth may indicate earnings instability. While revenue and asset growth demonstrate the company's ability to expand, the negative growth in earnings per share and net income requires attention to ensure sustainable profitability. Improving earnings stability is crucial for long-term growth.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-7.640.3835.8210.4413.28
Operating Profit Growth Rate-4.96-52.17112.7318.823.02
Earnings Per Share (EPS) Growth-0.41-111.29-808.4332.6539.62
Asset Growth Rate5.912.3317.511.5118.13
Net Income Growth Rate-1.59-111.29-814.293847.83
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.40

The financial ratios show mixed results, with adequate earnings per share and book value per share, but low dividend per share and high capital expenditures. While earnings per share and book value per share demonstrate the company's profitability and asset value, the low dividend per share and high capital expenditures suggest a focus on reinvesting earnings rather than distributing them to shareholders. Balancing these factors is crucial for maintaining shareholder satisfaction and funding future growth.

AverageAdjusted Earnings Per Share (Adjusted EPS)Average
AverageCash Earnings Per Share (Cash EPS)Average
AverageBook Value Per ShareAverage
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)7.75-0.886.257.6711.33
Cash Earnings Per Share (Cash EPS)11.753.1210.2511.4415.78
Book Value Per Share58.7557.56771.1187.22
Dividend Per Share (DPS)0.290.30.410.390.44
Capital Expenditures (CapEx)273052123131
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The profitability ratios demonstrate the company's ability to generate profits from its revenue and assets. The company is efficient in managing its operations and generating profit from its core business activities.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin15.964.4111.9913.4114.77
Return on Capital Employed (ROCE)134121313
Return on Equity (ROE)13.19-1.529.3310.7812.99
Return on Assets (ROA)13.376.2511.3212.0612.56
Operating Margin22.1210.5416.517.7519.28
Net Margin11.92-1.347.058.8111.5
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.33

The efficiency ratios suggest that the company faces challenges in effectively managing its assets and operations. There is room for improvement in optimizing asset utilization, inventory turnover, and receivables collection to enhance overall efficiency and profitability. Focus should be on improving asset turnover and streamlining operations to improve the company's performance.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.191.271.621.471.66
Inventory Turnover Ratio2.252.12.732.612.38
Receivables Turnover Ratio6.715.33.693.574.23
Days Sales in Inventory Ratio162.22173.81133.7139.85153.36
Receivable Days54.468.8798.92102.2486.29
Capital Turnover Ratio0.830.91.081.010.93
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.80

The coverage ratios suggest that the company has a strong ability to meet its interest and dividend obligations. The company's ability to cover its interest and dividend payments indicates financial stability and a lower risk of financial distress.

GoodInterest Coverage RatioGood
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio4.581.233.755.846.09
Equity Dividend Coverage Ratio2514.292025
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The solvency position shows a healthy capital structure with a conservative approach to debt. The company is relying more on equity than debt to finance its operations. The company's equity is significantly higher than its debt, demonstrating financial stability and a lower risk of financial distress.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.250.210.190.180.18
Debt to Equity Ratio0.330.270.230.220.22
Equity Ratio0.750.790.810.820.82
Debt To Asset Ratio0.180.140.120.120.13
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 5.18

The liquidity position, while not exceptional, suggests the company has some capacity to meet its short-term obligations. The current and quick ratios indicate an ability to cover current liabilities with current assets, but the cash ratio and operating cash flow ratio suggest reliance on less liquid assets. The weighted average calculation provides a balanced view, but there is room to improve the company's immediate liquidity position to handle unforeseen expenses or investment opportunities.

AverageCurrent RatioAverage
AverageQuick RatioAverage
WeakCash RatioWeak
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.641.431.481.541.68
Quick Ratio0.580.680.860.770.81
Cash Ratio0.20.020.10.110.11
Operating Cash Flow Ratio0.190.070.130.220.15
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 22 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5132.75Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.43Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.66Neutral105.0032.1966.00
4Innova Captab Ltd7.3637.88Overvalued243.0014.63141.00
5Hikal Ltd7.13-50.15Neutral220.00-3.95-49.00
6RPG Life Sciences Ltd7.1232.71Neutral147.0069.64115.00
7Morepen Laboratories Ltd7.1229.50Neutral126.001.2196.00
8Alembic Ltd7.067.59Undervalued90.004.85317.00
9Syncom Formulations (India) Ltd6.9217.26Undervalued77.000.8176.00
10Hester Biosciences Ltd6.5431.47Neutral87.0061.2457.00
11Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
12SMS Pharmaceuticals Ltd5.9434.36Neutral171.009.35102.00
13Gufic BioSciences Ltd5.4955.88Neutral151.006.3064.00
14Dishman Carbogen Amcis Ltd5.3827.35Neutral566.00-2.4597.00
15IOL Chemicals & Pharmaceuticals Ltd5.3127.36Undervalued269.004.69138.00
16Indoco Remedies Ltd5.26-22.51Neutral142.00-0.61-99.00
17Aarti Drugs Ltd5.0717.33Undervalued309.0018.54195.00
18Orchid Pharma Ltd4.85248.95Neutral41.008.9121.00
19Sun Pharma Advanced Research Company Ltd4.355.07Neutral1599.0047.831553.00
20Solara Active Pharma Sciences Ltd4.34-276.85Neutral187.00-1.50-7.00
21Zota Health Care Ltd3.97-59.69Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

The management of SMS Pharmaceuticals exhibits a mixed performance. While the company has demonstrated sales growth, there are inconsistencies in quarterly sales and profit growth. The operating profit margin has seen fluctuations, and a high cash conversion cycle raises concerns about operational efficiency. While promoter holding is good, these factors suggest a need for careful monitoring.

Category Metric Value Assessment
PROS Promoter Holding 66.27% Good promoter holding indicates aligned interests.
Sales Growth (2024) 35.86% Strong sales growth in 2024.
CONS Cash Conversion Cycle (2025) 237 days High cash conversion cycle indicates inefficiency.
OPM Fluctuation Unstable operating profit margins.
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
WeakStrategic & Operational IndicatorsWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

SMS Pharmaceuticals faces moderate risks including segment performance volatility. The company's financial leverage and high cash conversion cycle add to the risk profile. Continuous monitoring and strategic adjustments are necessary to mitigate these risks.

AverageOff-balance sheet exposure quantificationAverage
AverageSegment performance volatilityAverage
01.

Off-balance sheet exposure quantification

02.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10378.36Bullish
  3. SMA 20376.92Bullish
  4. SMA 50379.10Bullish
  5. EMA 10378.88Bullish
  6. EMA 20378.13Bullish
  7. EMA 50377.78Bullish
  8. DEMA 10380.18Bearish
  9. DEMA 20378.61Bullish
  10. DEMA 50378.34Bullish
  11. TEMA 10380.82Bearish
  12. TEMA 20379.61Bullish
  13. TEMA 50379.12Bullish
  14. MACD0.58Bullish
  15. ADX25.15Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI54.61Neutral
  3. CCI62.66Neutral
  4. ROC 92.41Bullish
  5. ROC 141.33Bullish
  6. ROC 250.90Bullish
  7. Stoch K60.60Neutral
  8. Stoch D59.99Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper383.23Neutral
  3. BB Middle376.92Neutral
  4. BB Lower370.60Neutral
  5. ATR3.57Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI55.05Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10376.98Bullish
  3. SMA 20377.61Bullish
  4. SMA 50375.24Bullish
  5. EMA 10378.05Bullish
  6. EMA 20377.76Bullish
  7. EMA 50377.85Bullish
  8. DEMA 10378.80Bullish
  9. DEMA 20378.17Bullish
  10. DEMA 50375.25Bullish
  11. TEMA 10379.92Bullish
  12. TEMA 20377.85Bullish
  13. TEMA 50378.94Bullish
  14. MACD0.33Bullish
  15. ADX36.03Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.05Neutral
  3. CCI34.84Neutral
  4. ROC 91.09Bullish
  5. ROC 140.98Bullish
  6. ROC 250.18Bullish
  7. Stoch K60.49Neutral
  8. Stoch D58.76Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper383.80Neutral
  3. BB Middle377.61Neutral
  4. BB Lower371.41Neutral
  5. ATR5.02Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI62.16Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10377.09Bullish
  3. SMA 20378.27Bullish
  4. SMA 50381.36Bearish
  5. EMA 10377.36Bullish
  6. EMA 20377.07Bullish
  7. EMA 50381.59Bearish
  8. DEMA 10377.79Bullish
  9. DEMA 20376.44Bullish
  10. DEMA 50372.99Bullish
  11. TEMA 10377.53Bullish
  12. TEMA 20379.35Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.29Bullish
  15. ADX31.63Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.86Neutral
  3. CCI6.94Neutral
  4. ROC 9-0.68Bearish
  5. ROC 14-0.78Bearish
  6. ROC 256.95Bullish
  7. Stoch K31.59Neutral
  8. Stoch D21.17Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper387.00Neutral
  3. BB Middle378.27Neutral
  4. BB Lower369.54Neutral
  5. ATR8.72Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI43.78Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10376.41Bearish
  3. SMA 20374.85Bearish
  4. SMA 50396.18Bearish
  5. SMA 100376.87Bearish
  6. SMA 200334.41Bullish
  7. EMA 10375.99Bearish
  8. EMA 20379.11Bearish
  9. EMA 50384.22Bearish
  10. EMA 100372.67Bullish
  11. EMA 200342.98Bullish
  12. DEMA 10375.11Bearish
  13. DEMA 20371.54Bullish
  14. DEMA 50387.38Bearish
  15. DEMA 100403.41Bearish
  16. DEMA 200394.78Bearish
  17. TEMA 10377.83Bearish
  18. TEMA 20371.06Bullish
  19. TEMA 50373.13Bullish
  20. TEMA 100398.63Bearish
  21. TEMA 200410.24Bearish
  22. MACD-5.02Bullish
  23. ADX15.40Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI45.32Neutral
  3. CCI-9.87Neutral
  4. ROC 141.33Bullish
  5. ROC 25-7.40Bearish
  6. Stoch K50.10Neutral
  7. Stoch D53.56Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper403.43Neutral
  3. BB Middle374.85Neutral
  4. BB Lower346.26Neutral
  5. ATR15.84Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI56.12Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20380.16Bullish
  3. SMA 50319.18Bullish
  4. EMA 20374.32Bullish
  5. EMA 50333.66Bullish
  6. DEMA 20402.31Bearish
  7. DEMA 50388.15Bearish
  8. TEMA 20397.29Bearish
  9. TEMA 50404.99Bearish
  10. MACD18.78Bearish
  11. ADX43.29Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.49Neutral
  3. CCI81.68Neutral
  4. ROC 142.05Bullish
  5. ROC 2523.18Bullish
  6. Stoch K22.16Neutral
  7. Stoch D29.46Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper437.63Neutral
  3. BB Middle380.15Neutral
  4. BB Lower322.68Neutral
  5. ATR37.19Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.73Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6360.00Bullish
  3. SMA 12311.03Bullish
  4. SMA 24285.44Bullish
  5. EMA 6358.87Bullish
  6. EMA 12326.28Bullish
  7. EMA 24282.47Bullish
  8. DEMA 6390.40Bearish
  9. DEMA 12376.33Bearish
  10. DEMA 24351.98Bullish
  11. TEMA 6391.84Bearish
  12. TEMA 12390.37Bearish
  13. TEMA 24373.31Bearish
  14. MACD68.23Bullish
  15. ADX36.60Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.28Neutral
  3. CCI146.21Overbought
  4. ROC 2580.74Bullish
  5. ROC 50294.92Bullish
  6. Stoch K60.93Neutral
  7. Stoch D57.06Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper404.93Neutral
  3. BB Middle281.68Neutral
  4. BB Lower158.43Neutral
  5. ATR59.87High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI88.14Overbought